ERBB2 and renal cell carcinoma: Autoimmunity has been a major problem in CAR targeting of carboanhydrase IX (G250), a renal cell carcinoma antigen also expressed at low levels on bile duct epithelia [24] and in a recent trial targeting Her2/neu (ErbB2) with fatal outcome [63].